Fujirebio Diagnostics, Incorporated
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$18.0M
Doctors Paid
66
Transactions
171
2024 Total
$2.2M
Payment Breakdown by Category
Royalty/License$15.2M (84.2%)
Research$1.2M (6.8%)
Consulting$816,776 (4.5%)
Food & Beverage$4,966 (0.0%)
Travel$573.73 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $15.2M | 11 | 84.2% |
| Unspecified | $1.2M | 60 | 6.8% |
| Consulting Fee | $816,776 | 42 | 4.5% |
| Grant | $790,000 | 5 | 4.4% |
| Honoraria | $5,000 | 1 | 0.0% |
| Food and Beverage | $4,966 | 40 | 0.0% |
| Education | $3,500 | 10 | 0.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,950 | 1 | 0.0% |
| Travel and Lodging | $573.73 | 1 | 0.0% |
Payments by Type
General
$16.8M
111 transactions
Research
$1.2M
60 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| FDI-209 & 213 | $206,362 | 0 | 4 |
| FDI-235 and 244 | $185,580 | 0 | 1 |
| Lumipulse In Vitro Study | $179,485 | 0 | 3 |
| Brain Natriuretic Peptide | $123,008 | 0 | 14 |
| FDI-244 | $91,516 | 0 | 1 |
| Not Applicable | $85,806 | 0 | 1 |
| FDI 68 (CA 19-9) & FDI 69 (CA 15-3) | $60,352 | 0 | 8 |
| FDI 68 (CA 19-9) & FDI 69 (CA 15-3) | $47,481 | 0 | 2 |
| FDI-235, FDI-244, FDI-253 | $41,643 | 0 | 1 |
| FDI-209 | $41,006 | 0 | 1 |
| FDI 209 - Lung Cancer | $22,797 | 0 | 1 |
| FDI 78 (Recurrence) & FDI 79 (Monitoring) Ovarian Cancer Study | $20,500 | 0 | 1 |
| Lumipulse Validation Studies | $17,908 | 0 | 1 |
| FDI 78 & FDI 79 (Ovarian Cancer) | $17,593 | 0 | 1 |
| FDI-213 | $14,168 | 0 | 2 |
| Ovarian Cancer Study | $14,050 | 0 | 4 |
| Lumipulse Vitamin D Study | $12,935 | 0 | 1 |
| FDI-78 & 79 | $9,112 | 0 | 1 |
| FDI 217 BNP | $7,000 | 0 | 1 |
| FDI-78 | $6,546 | 0 | 4 |
| HE4 & CA 125II Ovarian Cancer Study | $5,115 | 0 | 3 |
| Lumipulsa Beta Amyloid Testing | $5,000 | 0 | 1 |
| FDI-79 | $3,000 | 0 | 1 |
| FDI-78, FDI-79 | $1,500 | 0 | 1 |
| FDI-68 & 69 | $1,049 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Richard Moore, Md, MD | Gynecologic Oncology | Rochester, NY | $105,983 | $0 |
| Dr. Robert Knapp | Obstetrics & Gynecology | Lantana, FL | $96,250 | $0 |
| Jorge Nieva, M.d, M.D | Hematology & Oncology | Los Angeles, CA | $14,608 | $0 |
| Dr. Christopher Defilippi, M.d, M.D | Cardiovascular Disease | Baltimore, MD | $11,092 | $0 |
| Dr. Eric Gluck, M.d, M.D | Critical Care Medicine | Chicago, IL | $5,000 | $0 |
| Dr. William Hu, M.d., Ph.d, M.D., PH.D | Neurology | New Brunswick, NJ | $3,500 | $0 |
| Kenneth Chen, Md, MD | Endocrinology, Diabetes & Metabolism | Providence, RI | $3,497 | $0 |
| Kenneth Chen, Md, MD | Nephrology | Richmond, CA | $2,868 | $0 |
| Dr. Bryan Burt, M.d, M.D | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Los Angeles, CA | $2,400 | $0 |
| Unknown Provider | — | — | $2,300 | $0 |
| Dr. Edgardo Santos, Md, MD | Hematology & Oncology | Fort Lauderdale, FL | $2,258 | $0 |
| Dr. Pamela St Amand, Md, MD | Obstetrics & Gynecology | Beaumont, TX | $724.94 | $0 |
| Dr. Henry Gor, Md, MD | Obstetrics & Gynecology | Longview, TX | $724.94 | $0 |
| Dr. Randy Daniell, Md, MD | Specialist | Abilene, TX | $724.94 | $0 |
| Dr. Kathleen Phillipp, M.d, M.D | Public Health or Welfare | Sweetwater, TX | $724.94 | $0 |
| Dr. Robert Wheeler, Md, MD | Obstetrics & Gynecology | Longview, TX | $724.94 | $0 |
| Dr. David Vineyard, M.d, M.D | Obstetrics & Gynecology | Amarillo, TX | $724.94 | $0 |
| Dale Stovall, M.d, M.D | Reproductive Endocrinology | Dallas, TX | $724.94 | $0 |
| Dr. Douglas Galasko, Md, MD | Neurology | La Jolla, CA | $575.99 | $0 |
| Stephen Salloway, Md, MD | Neurology | Providence, RI | $500.00 | $0 |
| Dr. Gerald Feldman, Md Phd, MD PHD | Clinical Genetics (M.D.) | Detroit, MI | $400.00 | $0 |
| Dr. Okey Okoli, Md, MD | Obstetrics & Gynecology | San Antonio, TX | $374.94 | $0 |
| Denise De Los Santos, M.d, M.D | Obstetrics & Gynecology | San Antonio, TX | $374.94 | $0 |
| Dr. Charles Carroll, D.o, D.O | Obstetrics & Gynecology | Flowood, MS | $350.00 | $0 |
| Dr. Mehmet Bayram, M.d, M.D | Obstetrics | Commerce Twp, MI | $350.00 | $0 |
Ad
Top Products
- In-vitro diagnostic reagents $2.6M
Associated Products (1)
Payment Categories
- Food & Beverage $4,966
- Consulting $816,776
- Travel & Lodging $573.73
- Research $1.2M
- Royalties $15.2M
About Fujirebio Diagnostics, Incorporated
Fujirebio Diagnostics, Incorporated has made $18.0M in payments to 66 healthcare providers, recorded across 171 transactions in the CMS Open Payments database. In 2024, the company paid $2.2M. The top product by payment volume is In-vitro diagnostic reagents ($2.6M).
Payments were distributed across 24 medical specialties. The top specialty by payment amount is Gynecologic Oncology ($106,155 to 2 doctors).
Payment categories include: Food & Beverage ($4,966), Consulting ($816,776), Research ($1.2M), Travel & Lodging ($573.73), Royalties ($15.2M).
Fujirebio Diagnostics, Incorporated is associated with 1 products in the CMS Open Payments database.